Key result
Consumer activity monitors fail accuracy standards in heart failure patients, performing worse at slower speeds.
Observational
Answers are grounded in this paper and cite their sources.
INTRODUCTION: Although numerous activity trackers have been validated in healthy populations, validation is lacking in chronic heart failure patients who normally walk at a slower pace, making it difficult for researchers and clinicians to implement activity monitors during physical activity interventions. METHODS: Six consumer-level activity monitors were validated in a 3-day field study in patients with chronic heart failure and healthy individuals under free living conditions. Furthermore, the same devices were evaluated in a lab-based study during treadmill walking at speeds of 2.4, 3.0, 3.6, and 4.2 km·h-1. Concordance correlation coefficients (CCC) were used to evaluate the agreement between the activity monitors and the criterion, and mean absolute percentage errors (MAPE) were calculated to assess differences between each device and the criterion (MAPE <10% was considered as a threshold for validity). RESULTS: In the field study of healthy individuals, all but one of the activity monitors showed a substantial correlation (CCC ≥0.95) with the criterion device and MAPE <10%. In patients with heart failure, the correlation of only two activity monitors (Garmin vívofit 3 and Withings Go) was classified as at least moderate (CCC ≥0.90) and none of the devices had MAPE <10%. In the lab-based study at speeds 4.2 and 3.6 km·h-1, all activity monitors showed substantial to almost perfect correlations (CCC ≥0.95) with the criterion and MAPE in the range 1%-3%. However, at slower speeds of 3.0 and 2.4 km·h-1, the accuracy of all devices substantially deteriorated: their correlation with the criterion decreased below 90% and their MAPE increased to 4-8% and 10-45%, respectively. CONCLUSIONS: Even though none of the tested activity monitors fall within arbitrary thresholds for validity, most of them perform reasonably well enough to be useful tools that clinicians can use to simply motivate chronic heart failure patients to walk more.
No takes yet. Share an insight, caveat, or question.
Větrovský et al. (2019) conducted an observational in Chronic heart failure. Six consumer-level activity monitors (including Garmin vívofit 3 and Withings Go) vs. Criterion device was evaluated on Agreement and validity in measuring steps using concordance correlation coefficients (CCC) and mean absolute percentage error (MAPE <10% threshold). None of the six consumer-level activity monitors achieved a mean absolute percentage error <10% in chronic heart failure patients, and accuracy decreased at walking speeds ≤3.0 km/h.
Synapse has enriched 10 related papers. Consider them for comparative context: